Scale risk of cardiovascular disease tyna

Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas. Sa pangunahing (esensyal) na altapresyon, ito ay dahil sa impluwensya ng namamana, hilig sa mataas na presyon ng dugo sa konteksto ng hindi malusog na pamumuhay, masamang gawi, hindi malusog na pagkain, na nagdudulot ng labis na timbang. Dagdag pa ang stress, kalikasan, kakulangan sa tulog at aktibidad. Lahat ito ay negatibong nakakaapekto sa trabaho ng puso at sa tono ng mga daluyan ng dugo. Ang presyon ay unang tumataas nang hindi napapansin at pagkatapos ay mas nagiging malinaw.

I am happy to offer a scientific Text on the topic of scale for the assessment of the risk of cardiovascular disease in German: Scale for the assessment of the risk of cardiovascular diseases: principles and application Cardiovascular disease (CVD) is one of the main causes of morbidity and mortality. The early identification of risk factors and the quantitative assessment of individual risk are, therefore, of crucial importance for the prevention and Management of these diseases. 1. Definition and objectives of the risk scale A scale of Risk for cardiovascular disease, is a standardized Instrument developed on the Basis of epidemiological data, and it allows the individual risk of a patient for the Occurrence of cardiovascular events (e.g. myocardial infarction, stroke) within a certain time period (typically 10 years) to estimate. The primary objective of such a scale is: the identification of high-risk individuals; the support of medical decision-making in the therapy of recommendation; the Motivation of patients for the modification of lifestyle factors. 2. Known risk scale: SCORE One of the most widely used instruments in Europe, the SCORE scale (Systematic COronary Risk Evaluation) is. It was developed on the Basis of data from several large prospective studies and take into consideration the following parameters: Age (in years); Gender (male/female); systolic blood pressure (in mmHg); Total cholesterol (in mmol/l or mg/dl); Smoking status (Yes/no). The SCORE scale provides an estimate of the 10‑year risk of a fatal cardiovascular event. The results are divided into three risk categories: low risk (< 1 %); medium risk (1-5 %); high risk (> 5 %). 3. For more scales and developments In addition to SCORE more models exist, including: Framingham risk scale (originally developed in the United States, takes into account in addition to HDL‑cholesterol); QRISK3 (used in the UK, integrated additional factors, such as Diabetes, family history); ASCVD risk calculator (by the American Heart Association recommended). 4. Limitations and challenges Despite its usefulness, risk scale, have some limitations: they are based on population data and is not able to map the individual risk is always accurate; they do not take into account all relevant factors (e.g., psychosocial Stress, genetic predisposition); regional and ethnic differences can lead to distortions. 5. Conclusion Scale of risk for cardiovascular diseases are indispensable tools in clinical practice. Their continuous development and validation, taking into account new risk factors and demographic changes are needed to improve prevention policies and to reduce the global burden of cardiovascular diseases. If you want, I can make certain sections in more detail or further aspects!

Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas. I have two stents inserted in my heart and have been dealing with nerve-wracking irregular heartbeat my whole life. I decided to give Cardio Balance a try, and I thank God for it! Just after using it for a couple of weeks, my irregular heart beating became normal. I feel more ALIVE, young, and energetic.

Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate
Scale risk of cardiovascular disease

Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa.

Punan ang form ng konsultasyon at order Scale risk of cardiovascular disease. Lilinawin ng operator ang lahat ng detalye sa iyo at ipapadala namin ang iyong order.

Scale risk of cardiovascular disease. In diseases of the cardiovascular System exercise.

Diseases of the cardiovascular system: treatment and medication Belonging to the diseases of the cardiovascular system (HKS), one of the leading causes of death worldwide, is an effective treatment strategy is of crucial importance. Among the most common diseases such as atherosclerosis, hypertension, congestive heart failure, Coronary heart disease (CHD) and stroke. Pharmacotherapy plays a Central role, and is often combined with lifestyle-related measures. Principles of drug therapy The treatment goals for HKS diseases include: Lowering of blood pressure in hypertension; Reduction of atherogenic lipids (especially LDL cholesterol); Improvement of cardiac performance in heart failure; Prevention of thrombi and emboli; Relief of Angina pectoris. Important Groups Of Drugs ACE inhibitors (e.g., Enalapril, Ramipril) The Renin‑Angiotensin‑aldosterone‑System (RAAS), inhibit, reduce peripheral vascular resistance, and are used especially in the treatment of hypertension and congestive heart failure. They also show a cardioprotective effect. AT1‑receptor blockers (Sartans) (e.g., Losartan, Valsartan) Similar to the ACE inhibitors act on the RAAS, however, are used in patients with intractable side effects (cough) by ACE inhibitors as an Alternative. Beta-blockers (e.g., Metoprolol, Bisoprolol) The heart rate and blood pressure, reduce reduce the oxygen demand of the heart and are in CHD and heart failure is of great importance. Calcium channel blockers (e.g. amlodipine, Diltiazem) Act vasodilatierend and are particularly useful in hypertension and certain forms of Angina pectoris. Diuretics (eg, hydrochlorothiazide, furosemide) Lead to the propagation of the urinary excretion, thus lowering the blood volume and blood pressure. Furosemide is prescribed, especially in advanced heart failure. Statins (e.g., Atorvastatin, Rosuvastatin) The cholesterol synthesis to inhibit the liver metabolism, reduce the levels of LDL‑cholesterol and slow the progression of atherosclerosis. They are also used for secondary prevention after a myocardial infarction or stroke. Anticoagulants Acetylsalicylic acid (Asa): Inhibits platelet aggregation and is used in the prevention of heart attacks and strokes. Clopidogrel: Is often prescribed in combination with aspirin after stent implantation. Anticoagulants (e.g., Warfarin, Rivaroxaban, Dabigatran) Prevent the formation of blood clots, to be applied in the case of atrial fibrillation and to Prosthesis use in the heart. Combination therapy and individual adjustment In practice, medicines are often combined to enhance treatment effectiveness. For example, a combination of an ACE inhibitor and a beta‑blocker in heart failure or a diuretic may be, together with a Sartan in hypertension useful. The choice of medication depends on the individual diagnosis, the risk profile, the comorbidities and the impact. Conclusion The pharmacotherapy of diseases of the cardiovascular system is varied and is based on evidence-based guidelines. A targeted and individually tailored medication may improve Survival, enhance the quality of life and complications preventive encounter. Regular checks and Patient education are essential to ensure the long-term efficacy and safety of the therapy.